Octostim (Desmopressin Acetate)

Desmopressin Acetate is used in disorders that involve antidiuretic hormone pathways or coagulation factor deficiencies.

• Central diabetes insipidus: helps control excessive urine output and thirst.
• Nocturnal enuresis: reduces nighttime bedwetting episodes in children.
• Mild hemophilia A and von Willebrand disease: raises plasma levels of factor VIII and von Willebrand factor to improve clotting.

• Desmopressin acetate binds to V2 receptors on renal collecting‑duct cells, stimulating cyclic AMP production and promoting insertion of aquaporin‑2 water channels, which increases water reabsorption. It also triggers the release of stored factor VIII and von Willebrand factor from endothelial cells, enhancing haemostatic activity.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Nasal congestion or irritation (if administered nasally).
• Nausea or abdominal discomfort.
• Hyponatraemia: low blood sodium, usually mild.
• Flushing or warmth sensation.

Serious or Rare Side Effects

• Severe hyponatraemia leading to seizures or coma.
• Thrombotic events such as deep‑vein thrombosis.
• Allergic reactions including rash, itching or anaphylaxis.
• Hypertension or significant blood‑pressure rise.
• Cardiac arrhythmias in patients with electrolyte imbalance.

Desmopressin should be used with careful clinical oversight, particularly in patients at risk of fluid overload or electrolyte disturbance.

• Fluid restriction: limit intake to avoid hyponatraemia.
• Monitor sodium: regular blood‑sodium checks during therapy.
• Cardiovascular disease: use cautiously in hypertension or heart failure.
• Pregnancy and lactation: assess risk‑benefit, as safety data are limited.
• Concomitant anticoagulants: evaluate bleeding risk when used together.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Desmopressin can interact with several medicines that affect fluid balance, coagulation or blood pressure.

Major Interactions (Avoid)

• NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia.
• Carbamazepine: may reduce desmopressin effectiveness.
• Antidiuretic‑type drugs (e.g., chlorpropamide): additive water‑retention effect.

Moderate Interactions (Monitor Closely)

• Warfarin or other oral anticoagulants: may enhance bleeding control but require INR monitoring.
• ACE inhibitors or ARBs: potential for exaggerated blood‑pressure changes.
• Diuretics (especially thiazides): alter sodium balance, needing closer electrolyte surveillance.